Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome-Reference-Cited by-同舟云学术

Divergent LAG-3 versus BTLA, TIGIT, and FCRL3 expression in Sézary syndrome

Published:2019-01-14 Issue:8 Volume:60 Page:1899-1907
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Anzengruber Florian¹,Ignatova Desislava¹,Schlaepfer Tanja¹,Chang Yun-Tsan¹,French Lars E.¹,Pascolo Steve¹,Contassot Emmanuel¹,Bobrowicz Malgorzata¹²,Hoetzenecker Wolfram³,Guenova Emmanuella¹

Affiliation:

1. Department of Dermatology, University Hospital Zurich University of Zurich, Zurich, Switzerland;

2. Department of Immunology, Medical University of Warsaw, Warsaw, Poland;

3. Department of Dermatology, University Hospital Linz, Linz, Austria

Funder

Forschungskredit of the University of Zurich

Jubiläumsstiftung von SwissLife

Promedica Stiftung

Error! Hyperlink reference not valid.

European Commission Horizon 2020 Programme

Polish National Science Centre

EMBO

An anonymous further Foundation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://tandfonline.com/doi/pdf/10.1080/10428194.2018.1564827

Reference55 articles.

1. Current systemic therapeutic options for advanced mycosis fungoides and Sézary syndrome

2. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

3. Infections Complicating Mycosis Fungoides and Sézary Syndrome

4. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

5. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon;Blood Advances;2024-05-17

2. Role of Antigenic Stimulation in Cutaneous T-Cell Lymphomas;Journal of Investigative Dermatology;2023-12

3. The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma;Biomedicine & Pharmacotherapy;2023-10

4. Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma;Cancer Management and Research;2023-09

5. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma;British Journal of Dermatology;2023-07-06